PODD (Insulet) Cyclically Adjusted FCF per Share: $0.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PODD Insulet Corp PODD
81 GF Score
Price $143.34
GF Value $389.17
Valuation Significantly Undervalued
View Full Analysis

What is Insulet Cyclically Adjusted FCF per Share?

Insulet PODD -2.05% 81 Cyclically Adjusted FCF per Share is $0.11 as of Jun. 2026. GuruFocus rates PODD with a GF Score™ of 81/100 and a GF Value™ of $389.17 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Insulet's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.736. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.11 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 52.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 27.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Insulet was 52.90% per year. The lowest was -10.40% per year. And the median was 14.20% per year.

As of today (2026-08-16), Insulet's current stock price is $143.34. Insulet's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $0.11. Insulet's Cyclically Adjusted Price-to-FCF of today is 1,303.09.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Insulet was 5107.75. The lowest was 1283.36. And the median was 3713.13.


Insulet  (NAS:PODD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Insulet's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=143.34/0.11
=1,303.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Insulet was 5107.75. The lowest was 1283.36. And the median was 3713.13.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Insulet Cyclically Adjusted FCF per Share Related Terms


Insulet Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Insulet's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insulet Cyclically Adjusted FCF per Share Chart

Insulet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.03 -1.05 -1.03 -0.65 -0.11

Insulet Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.33 -0.22 -0.11 0.04 0.11

PODD vs GMED, PEN, BRKR: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Insulet's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insulet Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Insulet's Cyclically Adjusted Price-to-FCF falls into.


PODD
81GF Score
Insulet Corp PODD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Insulet Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Insulet's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.736/333.9520*333.9520
=0.736

Current CPI (Jun. 2026) = 333.9520.

Insulet Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.185 241.428 -0.256
201612 0.299 241.432 0.414
201703 -0.824 243.801 -1.129
201706 0.079 244.955 0.108
201709 0.250 246.819 0.338
201712 -0.129 246.524 -0.175
201803 -0.678 249.554 -0.907
201806 -1.032 251.989 -1.368
201809 -0.356 252.439 -0.471
201812 -0.065 251.233 -0.086
201903 -0.635 254.202 -0.834
201906 -0.613 256.143 -0.799
201909 0.112 256.759 0.146
201912 -0.047 256.974 -0.061
202003 -0.493 258.115 -0.638
202006 0.024 257.797 0.031
202009 0.263 260.280 0.337
202012 -1.055 260.474 -1.353
202103 -1.036 264.877 -1.306
202106 -0.073 271.696 -0.090
202109 -0.790 274.310 -0.962
202112 -0.859 278.802 -1.029
202203 -0.424 287.504 -0.492
202206 0.089 296.311 0.100
202209 0.328 296.808 0.369
202212 -0.526 296.797 -0.592
202303 -0.522 301.836 -0.578
202306 0.369 305.109 0.404
202309 0.456 307.789 0.495
202312 0.162 306.746 0.176
202403 0.862 312.332 0.922
202406 0.839 314.175 0.892
202409 1.071 315.301 1.134
202412 1.235 315.605 1.307
202503 0.649 319.799 0.678
202506 2.453 322.561 2.540
202509 1.339 324.800 1.377
202512 0.480 324.054 0.495
202603 1.225 330.213 1.239
202606 0.736 333.952 0.736

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.11 mean?
Insulet (PODD) has a Cyclically Adjusted FCF per Share of $0.11 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Insulet and its competitors.
Is Insulet's Cyclically Adjusted FCF per Share too high?
Insulet's current Cyclically Adjusted FCF per Share is $0.11. Overall, Insulet has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Insulet's Cyclically Adjusted FCF per Share compare to GMED and PEN?
Insulet's Cyclically Adjusted FCF per Share of $0.11 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Insulet and its competitors. Insulet's current Cyclically Adjusted FCF per Share is $0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insulet stock overvalued right now?
Based on GuruFocus' analysis, Insulet (PODD) is currently considered Significantly Undervalued. The stock's GF Value™ is $389.17, compared to a current price of $143.34 — trading 63.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.11. Insulet's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Insulet (PODD), the current Cyclically Adjusted FCF per Share is $0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insulet (PODD) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of $143.34 is trading 63.2% below its estimated GF Value™ of $389.17. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for PODD:

  • Cyclically Adjusted FCF per Share: $0.11
  • GF Value™: $389.17 vs. price of $143.34 (63.2% below fair value)
  • GF Score™: 81/100

No single metric tells the full story. See the PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
81GF Score

Get the complete analysis for PODD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$143.34
Price
$389.17
GF Value